Microbot Medical Inc
MBOT2.635USD
+0.085+3.33%
取引時間 （ET）15分遅れの株価
91.55M時価総額
損失額直近12ヶ月PER
詳細情報 Microbot Medical Inc 企業名
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
企業情報
企業コードMBOT
会社名Microbot Medical Inc
上場日Mar 25, 1992
最高経営責任者「CEO」Mr. Harel Gadot
従業員数21
証券種類Ordinary Share
決算期末Mar 25
本社所在地175 Derby St Bld 27
都市HINGHAM
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号02043
電話番号17818753605
ウェブサイトhttp://www.microbotmedical.com/
企業コードMBOT
上場日Mar 25, 1992
最高経営責任者「CEO」Mr. Harel Gadot
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Scott R. Burell
Mr. Scott R. Burell
Independent Director
Independent Director
--
--
Ms. Aileen Ptucha Stockburger, CPA
Ms. Aileen Ptucha Stockburger, CPA
Independent Director
Independent Director
--
--
Mr. Simon Sharon
Mr. Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Chief Technology Officer, General Manager of Microbot Israel
--
--
Mr. Martin J. Madden
Mr. Martin J. Madden
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
5.05%
Geode Capital Management, L.L.C.
0.78%
BlackRock Institutional Trust Company, N.A.
0.58%
MEDX Ventures Group LLC
0.34%
State Street Global Advisors (US)
0.34%
Other
92.91%
株主統計
株主統計
比率
The Vanguard Group, Inc.
5.05%
Geode Capital Management, L.L.C.
0.78%
BlackRock Institutional Trust Company, N.A.
0.58%
MEDX Ventures Group LLC
0.34%
State Street Global Advisors (US)
0.34%
Other
92.91%
種類
株主統計
比率
Investment Advisor
6.96%
Investment Advisor/Hedge Fund
1.74%
Research Firm
0.36%
Venture Capital
0.36%
Hedge Fund
0.26%
Other
90.31%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
93
3.70M
9.69%
-538.67K
2025Q1
89
2.58M
7.86%
-1.62M
2024Q4
78
1.58M
4.97%
-880.54K
2024Q3
70
1.52M
8.93%
-946.72K
2024Q2
71
1.56M
9.80%
-833.62K
2024Q1
69
2.54M
18.61%
-153.32K
2023Q4
67
2.61M
22.30%
+489.30K
2023Q3
65
2.09M
17.88%
-264.50K
2023Q2
64
2.33M
23.62%
-218.94K
2023Q1
63
2.51M
30.86%
-204.69K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
741.16K
2.04%
+281.62K
+61.28%
Mar 31, 2025
Geode Capital Management, L.L.C.
316.92K
0.87%
+174.26K
+122.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
236.10K
0.65%
+98.73K
+71.87%
Mar 31, 2025
MEDX Ventures Group LLC
136.85K
0.38%
--
--
Apr 15, 2025
State Street Global Advisors (US)
136.67K
0.38%
+110.60K
+424.24%
Mar 31, 2025
DNB Asset Management AS
114.82K
0.32%
--
--
Mar 31, 2025
Susquehanna International Group, LLP
104.18K
0.29%
+74.45K
+250.44%
Mar 31, 2025
Two Sigma Investments, LP
83.02K
0.23%
+72.29K
+673.87%
Mar 31, 2025
Northern Trust Investments, Inc.
71.06K
0.2%
+57.67K
+430.78%
Mar 31, 2025
UBS Financial Services, Inc.
41.13K
0.11%
+40.06K
+3765.23%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
比率0.02%
Dimensional US Core Equity 1 ETF
比率0%
iShares Core S&P Total U.S. Stock Market ETF
比率0%
Avantis US Small Cap Equity ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
